Country: Unjoni Ewropea
Lingwa: Ingliż
Sors: EMA (European Medicines Agency)
efmoroctocog alfa
Swedish Orphan Biovitrum AB (publ)
B02BD02
efmoroctocog alfa
ANTIHEMORRHAGICS, ,
Hemophilia A
Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).Elocta can be used for all age groups.
Revision: 4
Authorised
2015-11-18